Intrinsic Value of S&P & Nasdaq Contact Us

Biocept, Inc. BIOC NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
26/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — BIOC

Biocept, Inc. (BIOC) has a market capitalization of $450.79K and trades at $0.43. The 52-week range is 0.4349-0.4349.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-56.78, annual revenue of $25.86M.

The stock has a beta of 0.60, operates in the Healthcare sector.

Trading Data
Current Price$0.43
52-Week Range0.4349-0.4349
Volume572.52K
Market Cap$450.79K
Beta (1Y)0.60
Company
IPO Date2014-02-05
Employees50
CEODarrell Taylor
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS09072V6002
CUSIP09072V402
Income (Latest Year)
Revenue$25.86M
Gross Profit$-2.58M
EBITDA$-30.33M
Operating Income$-31.98M
Net Income$-32.09M
EPS$-56.78
EPS Diluted$-56.78
Shares Outstanding$565.13K
Balance Sheet (Latest Year)
Total Assets$30.87M
Current Assets$16.34M
Cash & ST Investments$12.9M
Total Liabilities$22.01M
Total Debt$12.11M
Net Debt$-788K
Total Equity$8.86M
Debt / Equity1.37
Valuation Ratios
P/E Ratio-0
P/S Ratio0.02
P/B Ratio0.05
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message